title: Phacoemulsification with intraocular lens implantation in patients with uveitis.
abstract: OBJECTIVE
  To investigate the safety and efficacy of phacoemulsification with intraocular lens implantation in eyes affected by uveitis.
  
  
  METHODS
  A retrospective case series is presented including casenote review and update patient examinations. Patient data were withdrawn from the Uveitis Clinic database. All uveitis patients undergoing phacoemulsification with intraocular lens implantation from August 1995 to November 2000 were included. A pre-operative preparation protocol was used. Operative and post-operative complications, degree of postoperative inflammation, best-corrected and final visual acuity were the main outcome measures.
  
  
  RESULTS
  Eighty-six eyes of 75 patients underwent surgery, which in 11 cases was combined with trabeculectomy. Mean follow-up was 24.1 months. Eight eyes (10%) had severe or fibrinous uveitis post-operatively. The mean delay between surgery and return to baseline treatment was 8.6 weeks. Posterior capsule opacification occurred in 42% of eyes and Nd-YAG capsulotomy was required in 21%. Cystoid macular oedema was seen in 2 eyes. Seventy-two per cent of eyes retain a visual acuity of 6/9 or better, and 87% of eyes retain a post-operative improvement of 2 or more lines of Snellen acuity.
  
  
  CONCLUSIONS
  With careful patient selection, appropriate pre-operative preparation, diligent surgery and close post-operative supervision, phacoemulsification with intraocular lens implantation is safe and effective in the great majority of eyes with uveitis.
authors.affiliation: Manchester Royal Eye Hospital, UK. njones@central.cmht.nwest.nhs.uk
authors.forename: P S
authors.initials: PS
authors.lastname: Suresh
authors.forename: N P
authors.initials: NP
authors.lastname: Jones
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D002386:Cataract / Q000209:etiology*; D005260:Female; D006801:Humans; D006988:Hyphema / Q000209:etiology; D053685:Laser Therapy / Q000706:statistics & numerical data; D007910:Lenses, Intraocular / Q000009:adverse effects*; D008269:Macular Edema / Q000209:etiology; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification / Q000009:adverse effects* / Q000379:methods; D012189:Retrospective Studies; D014130:Trabeculectomy / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014605:Uveitis / Q000150:complications* / Q000188:drug therapy; D014792:Visual Acuity
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal